Julie Janes
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 7
- Cancer, Lipids, and Metabolism 2
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism 3
- Biotechnology top 5%
- Cancer Research and Treatments 8
- Nephrology top 10%
- Molecular Biology top 10%
-
- Nerve injury and regeneration 3
-
- Cancer-related Molecular Pathways 3
-
- Virus-based gene therapy research 2
-
- Pain Mechanisms and Treatments 2
- Co-authors
- Francesco ParlatiMirna L.M. RodriguezMark K. BennettEvan R. LewisFrances ZhaoSusan D. DemoPeter J. ShwonekJinfu Yang
- Partner nations
- United States
In The Last Decade
Julie Janes
16 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Cancer Research 719
- Biochemistry 151
- Biotechnology 105
- Nephrology 79
- Molecular Biology 720
Countries citing papers authored by Julie Janes
This map shows the geographic impact of Julie Janes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Janes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Janes more than expected).
Fields of papers citing papers by Julie Janes
This network shows the impact of papers produced by Julie Janes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Janes. The network helps show where Julie Janes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Janes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2016 | 10 | |
| 4 | 2016 | 16 | |
| 5 | 2015 | 4 | |
| 6 | 2015 | 4 | |
| 7 | 2015 | 4 | |
| 8 | Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancerbreakdown → | 2014 | 797 |
| 9 | 2014 | 20 | |
| 10 | 2014 | 7 | |
| 11 | 2014 | 12 | |
| 12 | 2013 | 84 | |
| 13 | 2013 | 21 | |
| 14 | 2013 | 0 | |
| 15 | 2008 | 53 | |
| 16 | 2007 | 117 | |
| 17 | 2006 | 91 | |
| 18 | 2005 | 12 | |
| 19 | Raising perceptual awareness in work with women and girls | 1986 | 1 |
About Julie Janes
Julie Janes is a scholar working on Biotechnology, Cancer Research and Biochemistry, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Research and Treatments (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Amino Acid Enzymes and Metabolism (3 papers), Nerve injury and regeneration (3 papers), Cancer-related Molecular Pathways (3 papers), Virus-based gene therapy research (2 papers), Pain Mechanisms and Treatments (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (719 citations), Biochemistry (151 citations) and Biotechnology (105 citations). Julie Janes has collaborated with scholars based in United States. Frequent co-authors include Francesco Parlati, Mirna L.M. Rodriguez, Mark K. Bennett, Evan R. Lewis, Frances Zhao, Susan D. Demo, Peter J. Shwonek, Jinfu Yang, Taotao Wang and Andrew L. MacKinnon. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, Journal of Pharmacology and Experimental Therapeutics and Brain Behavior and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.